![Chris Anderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Chris Anderson currently works at DICE Therapeutics, Inc., as Secretary from 2023, Sigilon Therapeutics, Inc., as Secretary from 2023, and POINT Biopharma Global, Inc., as Secretary from 2023.
Chris Anderson active positions
| Companies | Position | Start |
|---|---|---|
| DICE THER | Corporate Secretary | 09/08/2023 |
| SIGILON THERAPEUTICS, INC. | Corporate Secretary | 11/08/2023 |
| POIT BIOP | Director/Board Member | 27/12/2023 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic treatments for chronic diseases | Health Technology |
POINT Biopharma Global, Inc.
 POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Chris Anderson
